Newsletter Signup
Where current and emerging technology trends meet.
TecTrendsInformation Sources, Inc.
  | About TecTrends | Email Signup | Contact Us
 Live Search:
Live Search | Articles | Companies | TecTerms | Products
  Loading TecTrends Live Search - please wait... 
View Noteworthy Articles      PRNewswire
 
Company

Onyx Pharmaceuticals Inc Products   
2100 Powell St
Emeryville,  CA  94608
United States
Telephone: (510) 597-6500
Fax: (510) 597-6600
URL: http://www.onyx-pharm.com
Email: info@onyx-pharm.com

Onyx Pharmaceuticals Incorporated became a commercial company in 2006. The company collaborates with Bayer Pharmaceuticals Corporation in developing drugs to treat a variety of cancers. Its first major product was a drug called Nexavar (R) (sorafenib) to treat advanced kidney cancer; Nexavar was approved by the FDA in December 2005 and is sold throughout the United States and Europe. Nexavar inhibits tumor growth by inhibiting tumor cell proliferation and cutting off blood supply to tumors. Onyx hopes to take the idea behind Nexavar and apply it to treatment of liver cancers, melanoma, lung cancer, breast cancer, and other cancers. Onyx Pharmaceuticals is headquartered in Emeryville, California.

Org. Type: Corporation Equity Type: Public
Company Status: Active
Symbol: NASDAQ:ONYX

Products:
Onyx Pharmaceuticals Inc--Company News

TecTerms:
 


Home About TecTrends About Us Contact Us Privacy Statement Terms and Conditions

TecTrends | P.O. Box 8120 | Berkeley CA 94707 | (510) 525-6220 | Email: tectrends@tectrends.com
© 2006 INFORMATION SOURCES INC | All rights reserved.